相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study
Carrie R. Houts et al.
QUALITY OF LIFE RESEARCH (2021)
Systematic review of outcomes and endpoints in acute migraine clinical trials
Carrie R. Houts et al.
HEADACHE (2021)
Systematic review of outcomes and endpoints in preventive migraine clinical trials
James S. McGinley et al.
HEADACHE (2021)
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial
Paul K. Winner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina et al.
CEPHALALGIA (2020)
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
Leon F. Garcia-Martinez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Richard B. Lipton et al.
NEUROLOGY (2020)
Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT-6) Total and Item-Specific Scores in Chronic Migraine
Carrie R. Houts et al.
HEADACHE (2020)
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study
Stephen Silberstein et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing
David W. Dodick et al.
HEADACHE (2020)
Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Dawn C. Buse et al.
HEADACHE (2019)
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Kathleen B. Digre
HEADACHE (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Triggers, Protectors, and Predictors in Episodic Migraine
Michael J. Marmura
CURRENT PAIN AND HEADACHE REPORTS (2018)
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Paolo Martelletti et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study
Dawn C. Buse et al.
MAYO CLINIC PROCEEDINGS (2016)
Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
Richard B. Lipton et al.
HEADACHE (2015)
The diagnosis and treatment of chronic migraine
Mark W. Weatherall
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Defining the Differences Between Episodic Migraine and Chronic Migraine
Zaza Katsarava et al.
CURRENT PAIN AND HEADACHE REPORTS (2012)
Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
A. M. Blumenfeld et al.
CEPHALALGIA (2011)
Temporomandibular disorders and cutaneous allodynia are associated in individuals with migraine
D. B. Grossi et al.
CEPHALALGIA (2009)
Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
Julie Munakata et al.
HEADACHE (2009)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
分享论文
